Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024

Description

Cell and gene therapy supply chain and logistics encompass the systematic coordination and management of materials, information, and resources essential for the development, production, and distribution of cell and gene therapies, ensuring their safe and effective administration to patients. These services deliver advanced treatments to patients, upholding the highest standards of safety and efficacy throughout the entire supply chain.

Various software solutions play crucial roles in these processes, including cell orchestration platforms, enterprise manufacturing systems, inventory management systems, laboratory information management systems, logistics management systems, patient management systems, quality management systems, and tracking and tracing systems. A cell orchestration platform is a software or technological platform facilitating the coordination, management, and integration of diverse processes related to cell therapy development, manufacturing, and delivery. It streamlines and automates tasks associated with cell sourcing, manufacturing, quality control, logistics, patient tracking, and data management. These platforms are deployed as cloud-based or on-premises solutions and are utilized in cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment, storage medium, cryogenic packout kits, and other components. Applications include donor eligibility assessment, sample collection, manufacturing, logistics, patient verification, and treatment follow-up. End-users encompass biobanks, cell therapy labs, hospitals, research institutes, and commercial organizations.

The cell and gene therapy supply chain/logistics research report is one of a series of new reports from The Business Research Company that provides cell and gene therapy supply chain/logistics market statistics, including the cell and gene therapy supply chain/logistics industry's global market size, regional shares, competitors with a cell and gene therapy supply chain/logistics market share, detailed cell and gene therapy supply chain/logistics market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy supply chain/logistics industry. This cell and gene therapy supply chain/logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell and gene therapy supply chain/logistics market size has grown rapidly in recent years. It will grow from $1.25 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historical period can be ascribed to the increasing prevalence of chronic diseases, the effective management of supply chain requirements, heightened focus on maintaining drug integrity, the evolution of regulatory frameworks, and a growing emphasis on risk mitigation and compliance.

The cell and gene therapy supply chain/logistics market size is expected to see rapid growth in the next few years. It will grow to $2.15 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The anticipated growth in the forecast period can be associated with the expansion of personalized medicine, the advancement of cell-free therapies, the increasing prevalence of chronic diseases, the growth of the global cell therapy manufacturing market, and the effective utilization of supply chain requirements. Key trends expected in the forecast period encompass a rise in research and development expenditure, the adoption of advanced technologies, favorable initiatives and programs to enhance accessibility, and the formation of partnerships and collaborations among cell and gene therapy companies, supply chain providers, and logistics companies, offering customizable services to support various stages of patient identification

The growth of the cell and gene therapy supply chain/logistics market is fueled by the rising demand for cell and gene therapies. These innovative medical treatments, which involve modifying cells or genes to address diseases, present potential breakthroughs for previously untreatable conditions. Ensuring the proper storage conditions, including temperature control, is crucial for these therapies, and supply chain and logistics services play a vital role in sourcing, distributing, and storing them. For instance, in February 2022, private investment in cell and gene therapy reached $68 billion, and the number of approved therapies saw a 10% growth in 2021, as reported by Cell & Gene, a US-based online resource for research scholars. Hence, the increasing need for cell and gene therapies is a driving force in the cell and gene therapy supply chain/logistics market.

The anticipated growth of the cell and gene therapy supply chain/logistics market is further supported by the increasing demand for personalized medicine. Personalized medicine involves tailoring medical decisions, interventions, and drug therapies to individual patients, and the supply chain/logistics services for cell and gene therapies play a critical role in delivering these precision medicines safely and effectively. Temperature monitoring is incorporated to maintain integrity throughout the supply chain. As of October 2022, there were over 75,000 genetic testing products and 300 personalized medicines, highlighting the growing demand for personalized medical solutions, according to reports published by STAT, a US-based health-oriented news company. Therefore, the rising demand for personalized medicine is a key driver of the growth in the cell and gene therapy supply chain/logistics market.

The adoption of modern technology platforms stands out as a key trend in the cell and gene therapy supply chain/logistics markets. Major companies within this sector are actively developing advanced technology platforms to enhance their position in the market. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company specializing in cell and gene therapy supply chain logistics, introduced the Cell and Gene Therapy (CGT) Integration Hub. This innovative hub, powered by AmerisourceBergen's customer relationship management (CRM) system, can seamlessly integrate into the biopharma platform, enabling improved monitoring of the development and delivery processes for cell and gene therapies.

Leading companies in the cell and gene therapy supply chain/logistics sector are concentrating on introducing next-generation solutions, including off-the-shelf cell orchestration platforms. These platforms offer streamlined supply chain management, pre-designed modules, industry-proven processes, rapid deployment, and integration capabilities. For example, in January 2022, TrakCel Limited, a UK-based software company, launched OCELLOS Lite, a pre-designed, modular, and validated solution for managing the supply chain and logistics of cell and gene therapies. OCELLOS Lite facilitates supply chain process management from clinical development phases to commercialization and boasts quick deployment, making it one of the most straightforward and rapid solutions.

In April 2022, Cryoport Systems LLC, a US-based provider of temperature-controlled logistics services, acquired Cell&Co BioServices for $6.2 million. This strategic acquisition enabled Cryoport to expand its global supply chain network and better cater to the needs of the regenerative medicine industry. Cell&Co BioServices, based in France, is a supply chain management services provider for biological, pharmaceutical, and clinical samples throughout their life cycle.

Major companies operating in the cell and gene therapy supply chain/logistics market report are AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.

North America was the largest region in the cell and gene therapy supply chain/logistics market in 2023. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cell and gene therapy supply chain/logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell and gene therapy supply chain and logistics market includes revenues earned by entities by providing sourcing and collection, quality testing, distribution, and transportation services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell And Gene Therapy Supply Chain/Logistics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell and gene therapy supply chain/logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell and gene therapy supply chain/logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell and gene therapy supply chain/logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type Of Software Solution: Cell Orchestration Platform; Enterprise Manufacturing System; Inventory Management System; Laboratory Information Management System; Logistics Management System; Patient Management System; Quality Management System; Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution; On-Premises Solution
3) By Component: Cryogenic Shippers; Cryogenic Storage Freezers; Ultra-Low Freezers; Cold Chain Management Systems; Shipment; Storage Medium; Cryogenic Packout Kits; Other Components
4) By Application Area: Donor Eligibility Assessment; Sample Collection; Manufacturing; Logistics; Patient Verification; Treatment Follow-Up
5) By End User: Biobank; Cell Therapy Lab; Hospital; Research Institute; Commercial Organization
Companies Mentioned: AmerisourceBergen Corporation; United Parcel Service; Thermo Fisher Scientific Inc.; Avantor Sciences; Lonza Group AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r14125

1. Executive Summary

2. Cell And Gene Therapy Supply Chain/Logistics Market Characteristics

3. Cell And Gene Therapy Supply Chain/Logistics Market Trends And Strategies

4. Cell And Gene Therapy Supply Chain/Logistics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cell And Gene Therapy Supply Chain/Logistics Market Size and Growth

5.1. Global Cell And Gene Therapy Supply Chain/Logistics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cell And Gene Therapy Supply Chain/Logistics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cell And Gene Therapy Supply Chain/Logistics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell And Gene Therapy Supply Chain/Logistics Market Segmentation

6.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cell Orchestration Platform
Enterprise Manufacturing System
Inventory Management System
Laboratory Information Management System
Logistics Management System
Patient Management System
Quality Management System
Tracking And Tracing System
6.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Mode Of Deployment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cloud-Based Solution
On-Premises Solution
6.3. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cryogenic Shippers
Cryogenic Storage Freezers
Ultra-Low Freezers
Cold Chain Management Systems
Shipment
Storage Medium
Cryogenic Packout Kits
Other Components
6.4. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Donor Eligibility Assessment
Sample Collection
Manufacturing
Logistics
Patient Verification
Treatment Follow-Up
6.5. Global Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Biobank
Cell Therapy Lab
Hospital
Research Institute
Commercial Organization

7. Cell And Gene Therapy Supply Chain/Logistics Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cell And Gene Therapy Supply Chain/Logistics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market

8.1. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell And Gene Therapy Supply Chain/Logistics Market

9.1. China Cell And Gene Therapy Supply Chain/Logistics Market Overview
9.2. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell And Gene Therapy Supply Chain/Logistics Market

10.1. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell And Gene Therapy Supply Chain/Logistics Market

11.1. Japan Cell And Gene Therapy Supply Chain/Logistics Market Overview
11.2. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell And Gene Therapy Supply Chain/Logistics Market

12.1. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market

13.1. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell And Gene Therapy Supply Chain/Logistics Market

14.1. South Korea Cell And Gene Therapy Supply Chain/Logistics Market Overview
14.2. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market

15.1. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
15.2. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell And Gene Therapy Supply Chain/Logistics Market

16.1. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell And Gene Therapy Supply Chain/Logistics Market

17.1. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell And Gene Therapy Supply Chain/Logistics Market

18.1. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell And Gene Therapy Supply Chain/Logistics Market

19.1. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell And Gene Therapy Supply Chain/Logistics Market

20.1. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market

21.1. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market Overview
21.2. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell And Gene Therapy Supply Chain/Logistics Market

22.1. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell And Gene Therapy Supply Chain/Logistics Market

23.1. North America Cell And Gene Therapy Supply Chain/Logistics Market Overview
23.2. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell And Gene Therapy Supply Chain/Logistics Market

24.1. USA Cell And Gene Therapy Supply Chain/Logistics Market Overview
24.2. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell And Gene Therapy Supply Chain/Logistics Market

25.1. Canada Cell And Gene Therapy Supply Chain/Logistics Market Overview
25.2. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell And Gene Therapy Supply Chain/Logistics Market

26.1. South America Cell And Gene Therapy Supply Chain/Logistics Market Overview
26.2. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell And Gene Therapy Supply Chain/Logistics Market

27.1. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell And Gene Therapy Supply Chain/Logistics Market

28.1. Middle East Cell And Gene Therapy Supply Chain/Logistics Market Overview
28.2. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell And Gene Therapy Supply Chain/Logistics Market

29.1. Africa Cell And Gene Therapy Supply Chain/Logistics Market Overview
29.2. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Type Of Software Solution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By Application Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cell And Gene Therapy Supply Chain/Logistics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Supply Chain/Logistics Market Competitive Landscape
30.2. Cell And Gene Therapy Supply Chain/Logistics Market Company Profiles
- 30.2.1. AmerisourceBergen Corporation
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. United Parcel Service
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Avantor Sciences
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Lonza Group AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cell And Gene Therapy Supply Chain/Logistics Market Other Major And Innovative Companies

31.1. Arvato Group
31.2. Catalent Inc.
31.3. Charles River Laboratories International
31.4. Parexel International Corporation
31.5. Cytiva
31.6. Almac Group
31.7. World Courier
31.8. Sharp Packaging Services
31.9. PCI Pharma Services
31.10. Cryoport Inc.
31.11. Brooks Life Sciences
31.12. BioLife Solutions Inc.
31.13. Biocair Inc.
31.14. QuickSTAT
31.15. Clarkston Consulting Inc.

32. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Benchmarking

33. Global Cell And Gene Therapy Supply Chain/Logistics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell And Gene Therapy Supply Chain/Logistics Market

35. Cell And Gene Therapy Supply Chain/Logistics Market Future Outlook and Potential Analysis

35.1 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Countries Offering Most New Opportunities
35.2 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Segments Offering Most New Opportunities
35.3 Cell And Gene Therapy Supply Chain/Logistics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer